Dayspring Shows Superior Outcomes in Adults Over 65 and Phlebolymphedema Patients
Koya Medical announced new analyses from the TEAYS randomized controlled trial showing that its Dayspring compression system provides significantly better outcomes in limb volume reduction, quality of life, and adherence when compared to an advanced pneumatic compression device for both adults aged 65 and older and patients with phlebolymphedema.
Findings extend published head-to-head evidence for Dayspring across two clinically important lower-extremity lymphedema populations. DALLAS, July 23, 2026 /PRNewswire/ — Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for venous and lymphatic…